Impact of Local Lidocaine Paravertebral Cervical Injection on Cervicogenic Dizziness Symptoms
Status:
ENROLLING_BY_INVITATION
Trial end date:
2025-09-15
Target enrollment:
Participant gender:
Summary
at least 42 patients affected by cervicogenic dizziness will be allocated to the experimental group or in the placebo group. in the first group patients will received 2 paravertebral intramuscular injection of lidocaine 0.5% while in the placebo group they will received saline solution with the same injection technique. patients will be evaluated by subjective and objective testing before the treatment, immediatly and 3 months after the treatment.